The Loss of Extrastriatal As Well As Striatal [123I]FP-CIT Binding Is More Pronounced in MSA-P and PSP Than in Parkinson's Disease

被引:0
|
作者
Joling, M. [1 ]
Vriend, C. [1 ]
Van den Heuvel, O. A. [1 ]
Raijmakers, P. G. H. M. [1 ]
Berendse, H. W. [1 ]
Booij, J. [2 ]
机构
[1] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands
[2] Acad Med Ctr, Amsterdam, Netherlands
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
P277
引用
收藏
页码:S632 / S632
页数:1
相关论文
共 50 条
  • [21] Diagnostic value of micrographia in Parkinson's disease: a study with [123I]FP-CIT SPECT
    Eklund, Mikael
    Nuuttila, Simo
    Joutsa, Juho
    Jaakkola, Elina
    Makinen, Elina
    Honkanen, Emma A.
    Lindholm, Kari
    Vahlberg, Tero
    Noponen, Tommi
    Ihalainen, Toni
    Murtomaki, Kirsi
    Nojonen, Tanja
    Levo, Reeta
    Mertsalmi, Tuomas
    Scheperjans, Filip
    Kaasinen, Valtteri
    JOURNAL OF NEURAL TRANSMISSION, 2022, 129 (07) : 895 - 904
  • [22] Reduced striatal [123I]FP-CIT binding in PARK6-linked parkinsonism
    Hamscho, N
    Menzel, C
    Döbert, N
    Kessler, K
    Auburger, G
    Grünwald, F
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S371 - S371
  • [23] Case Report: Bupropion Reduces the [123I]FP-CIT Binding to Striatal Dopamine Transporter
    Milenkovic, Ivan
    Bartova, Lucie
    Papageorgiou, Konstantinos
    Kasper, Siegfried
    Traub-Weidinger, Tatjana
    Winkler, Dietmar
    FRONTIERS IN PSYCHIATRY, 2021, 12
  • [24] Diagnostic value of asymmetric striatal D2 receptor upregulation in Parkinson's disease:: an [123I]IBZM and [123I]FP-CIT SPECT study
    Verstappen, C. C. P.
    Bloem, B. R.
    Haaxma, C. A.
    Oyen, W. J. G.
    Horstink, M. W. I. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (04) : 502 - 507
  • [25] Diagnostic value of asymmetric striatal D2 receptor upregulation in Parkinson’s disease: an [123I]IBZM and [123I]FP-CIT SPECT study
    C. C. P. Verstappen
    B. R. Bloem
    C. A. Haaxma
    W. J. G. Oyen
    M. W. I. M. Horstink
    European Journal of Nuclear Medicine and Molecular Imaging, 2007, 34 : 502 - 507
  • [26] Transcranial sonography and [123I]FP-CIT SPECT disclose complementary aspects of Parkinson's disease
    Spiegel, J
    Hellwig, D
    Möllers, MO
    Behnke, S
    Jost, W
    Fassbender, K
    Samnick, S
    Dillmann, U
    Becker, G
    Kirsch, CM
    BRAIN, 2006, 129 : 1188 - 1193
  • [27] Thalamic 123I FP-CIT uptake in a patient with clinical diagnosis of Parkinson's disease and depression
    Schillaci, Orazio
    Chiaravalloti, Agostino
    Di Pietro, Barbara
    Stefani, Alessandro
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2012, 15 (01): : 74 - 75
  • [28] [123I]FP-CIT imaging in patients with Parkinson's disease: The effect of dopamine agonist drugs
    Volterrani, Duccio
    Ceravolo, Roberto
    Manca, Gianpiero
    Filidei, Elena
    Chiacchio, Serena
    Guidoccio, Federica
    Frosini, Daniela
    Locantore, Luisa
    Mariani, Giuliano
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [29] The effect of dopamine agonist drugs on [123I]FP-CIT imaging in patients with Parkinson's Disease
    Volterrani, D.
    Ceravolo, R.
    Manca, G.
    Rossi, M.
    Kiferle, L.
    Rizza, E.
    Mattone, V.
    Pesella, F.
    Frosini, D.
    Murri, L.
    Bonuccelli, U.
    Mariani, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S112 - S112
  • [30] The role of [123I]-FP-CIT SPECT in the diagnosis and clinical management of Parkinson's Disease.
    Feggi, L. M.
    Panareo, S.
    Sensi, C.
    Fabbri, S.
    Casali, M.
    Fainardi, E.
    Cittanti, C.
    Giganti, M.
    Prandini, N.
    Bagatin, E.
    Costanzo, A.
    Mangherini, S.
    Preda, F.
    Quatrale, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S98 - S98